Pediatric research 'personalized'? International perspectives on the return of results

Bartha Maria Knoppers1, Amélie Rioux2, Ma'n H Zawati2

  • 1Centre of Genomics & Policy, McGill University/Genome Quebec Innovation Centre, Montréal (Québec), Canada. bartha.knoppers@mcgill.ca.

Insights

New sequencing technologies challenge the

Area of Science:

  • Pediatric research ethics
  • Genomic medicine
  • Bioethics

Background:

  • The principle of 'best interests of the child' traditionally guides pediatric research decision-making.
  • Advancements in sequencing technologies introduce complexities regarding the return of research results and incidental findings.
  • Existing ethical frameworks require re-evaluation in light of personalized medicine.

Purpose of the Study:

  • To analyze international and national approaches to returning research results and incidental findings in pediatric research.
  • To examine how new sequencing technologies impact decision-making principles in pediatric research.
  • To identify emerging pediatric policy trends concerning personalized genetic information.

Main Methods:

  • Comparative analysis of policies in the USA, Canada, France, Spain, and the UK.
  • Review of legal and ethical guidelines related to pediatric research and genetic testing.
  • Examination of case studies on the return of incidental findings in childhood.

Main Results:

  • Significant variation exists in international and national policies regarding the return of research results.
  • Pediatric policies are increasingly context-specific, adapting to individual child needs.
  • The concept of 'personalized' pediatric policy emphasizes clinical significance and actionability during childhood.

Conclusions:

  • The interpretation of 'best interests of the child' is evolving due to genomic advancements.
  • Emerging pediatric policies reflect a personalized approach to managing genetic information.
  • International collaboration is crucial for developing consistent ethical guidelines in pediatric genomic research.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...